Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
We describe how low index readings can signal weakening momentum, possible capitulation, or upcoming reversals, with practical interpretation tips.
21,854 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
A compact team aims to redefine payments by moving crypto cards onto an Ethereum layer-2. This deep dive explains how...
Oil markets bounce as Strait of Hormuz risks flare and Beijing delays a high-stakes summit. The United States undermi...
A fresh wave of legal headlines rattled the markets, pulling down a big‑name hardware stock and lifting caution acros...
How did xplr (xifr) perform in Q1 2026, and what does it mean for 2026 earnings guidance? This article breaks down th...
Oil flows are shifting as the Strait of Hormuz crisis intensifies, pushing the U.S. to export crude to Australia. Mar...
Target just gave investors a fresh reason to rethink risk and opportunity in retail. After a solid earnings beat and ...
Nvidia and Broadcom lead the AI chip market, but which one deserves a place in a modern portfolio? This guide breaks ...
Aurora Cannabis faces a pivotal year in 2026. This guide breaks down what to expect in aurora (acb) 2026 earnings, ho...
A Bloomberg-sparked rumor could change how AI compute is bought and sold. If Amazon starts selling its custom AI chip...
Alcoa faced a sharp weekly decline as aluminum prices cooled and geopolitics added volatility. This guide breaks down...
Vietnam and the Philippines have been upgraded to upper-middle-income status, signaling a new growth phase and bringi...